GUCA1C
Guanylyl cyclase-activating protein 3
Also known as: GCAP3, GUC1C_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O95843
- Gene
- GUCA1C
- Ensembl
- ENSG00000138472
- Chromosome
- 3
- Canonical length
- 209 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Focal adhesion sites
OverviewNCBI Gene
Predicted to enable calcium ion binding activity and calcium sensitive guanylate cyclase activator activity. Predicted to be involved in regulation of signal transduction. Predicted to be located in photoreceptor disc membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
209 residues, UniProt reviewed canonical sequence.
>O95843|GUCA1C
1 MGNGKSIAGD QKAVPTQETH VWYRTFMMEY PSGLQTLHEF KTLLGLQGLN QKANKHIDQV
61 YNTFDTNKDG FVDFLEFIAA VNLIMQEKME QKLKWYFKLY DADGNGSIDK NELLDMFMAV
121 QALNGQQTLS PEEFINLVFH KIDINNDGEL TLEEFINGMA KDQDLLEIVY KSFDFSNVLR
181 VICNGKQPDM ETDSSKSPDK AGLGKVKMKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GUCA1C can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.35
- Highest tissue expression
- 275 nTPM
Expression across tissuesHPA
Tissue
- retina: 275 nTPM
- pancreas: 39 nTPM
- heart muscle: 15 nTPM
- stomach: 6 nTPM
- choroid plexus: 4.9 nTPM
- urinary bladder: 2.8 nTPM
Single-cell type
- cone photoreceptor cells: 596 nCPM
- early spermatids: 49 nCPM
- parietal cells: 35 nCPM
- pancreatic acinar cells: 26 nCPM
- thymocytes: 22 nCPM
- innate lymphoid cells: 19 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- choroid plexus: 2.3 nTPM
- cerebral cortex: 2.2 nTPM
- hypothalamus: 1.6 nTPM
- hippocampal formation: 1.2 nTPM
- amygdala: 0.7 nTPM
- basal ganglia: 0.2 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.88
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.32
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GUCA1C as an antibody target. Whether an autoantibody or antibody against GUCA1C could matter depends on whether native GUCA1C is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GUCA1C is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label GUCA1C as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...